Zobrazeno 1 - 10
of 1 238
pro vyhledávání: '"chronic nonmalignant pain"'
Autor:
Jaroslava Raudenská, Veronika Šteinerová, Šárka Vodičková, Martin Raudenský, Marie Fulková, Ivan Urits, Omar Viswanath, Giustino Varrassi, Alena Javůrková
Publikováno v:
Pain and Therapy, Vol 12, Iss 6, Pp 1309-1337 (2023)
Abstract Chronic nonmalignant pain is recognized as a complex, dynamic, phenomenological interplay between biological, psychological, and social factors that are individual to the person suffering from it. Therefore, its management and treatment ough
Externí odkaz:
https://doaj.org/article/25fd513bf6b14079aebe1ab9b3d2a064
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
IntroductionThe COVID-19 pandemic has had a variable effect on vulnerable populations, including patients with chronic pain who rely on opioid treatment or have comorbid opioid use disorder. Limited access to care due to isolation measures may lead t
Externí odkaz:
https://doaj.org/article/9e34d3ee7ea64298a7d8b4bb1536d78d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Opioid Management. 10
Both short-acting (SA) opioids and long-acting (LA) opioids have been used for chronic pain (defined as pain lasting >3 months). SA opioids have a duration of action ranging between 2 and 4 hours, result in rapidly fluctuating drug levels and are sui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eb6fbcfddefc665bbe6164e61a014b4
https://doi.org/10.5055/jom.2014.0229
https://doi.org/10.5055/jom.2014.0229
Autor:
Paul A. Sloan
Publikováno v:
Journal of Opioid Management. 10
Chronic pain of nonmalignant nature (CNMP) is often treated with chronic opioid therapy (COT). Although many guidelines exist to help the clinician use COT in a safe and effective manner, many controversies surrounding the exact prescribing practices
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb1fdecde5000d0785df357d4b836bd
https://doi.org/10.5055/jom.2014.0231
https://doi.org/10.5055/jom.2014.0231
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
David M. Schultz, Robert Spencer, Katherine Stromberg, Todd Weaver, Alaa Abd-Elsayed, Aaron K. Calodney
Publikováno v:
Neuromodulation
Objectives To assist in assessment of therapy risks and benefits of targeted drug delivery (TDD) for chronic nonmalignant pain using registry data on product performance, adverse events, and elective device replacement. Materials and Methods The Prod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d7aa2a28685cf04bc83273c4ad3f9ff
https://doi.org/10.1111/ner.13353
https://doi.org/10.1111/ner.13353
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Pathos, Vol 18, Iss 1, Pp 15-25 (2011)
The therapeutic efficacy and appearance of side effects of opioid drugs is strongly conditioned by the patient’s individual characteristics. It is impossible to know the patient’s particular pharmacogenomic connotations which determine those phen
Externí odkaz:
https://doaj.org/article/59e0436d21494a7a8499235763986eaa
Autor:
Ute Essner, Gerhard H. H. Müller-Schwefe, Martin Storr, Johannes Horlemann, Michael A Ueberall
Publikováno v:
Current medical research and opinion. 38(1)
Drug-induced constipation (DIC) is a well-known comorbidity of cancer pain, however, data on its prevalence in nonmalignant pain (NMP) and its biopsychosocial effects are few.To assess the prevalence and impact of DIC in patients with NMP.Exploratory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adfff44ed173bb2882a22006a052a2da
https://pubmed.ncbi.nlm.nih.gov/34617483
https://pubmed.ncbi.nlm.nih.gov/34617483